Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

6-Methyl-nicotinic acid.

ABSTRACT: All non-H atoms of the title compound, C(7)H(7)NO(2), are nearly coplaner, the r.m.s. deviation being 0.0087?Å. In the crystal, the partially overlapped arrangement and the face-to-face distance of 3.466?(17)?Å between parallel pyridine rings of neighboring mol-ecules indicates the existence of ?-? stacking. Inter-molecular O-H?N hydrogen bonding and weak C-H?O hydrogen bonding are present in the crystal structure.

SUBMITTER: Pan ML

PROVIDER: S-EPMC3200684 | biostudies-literature | 2011 Sep

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

6-Methyl-nicotinic acid.

Pan Mei-Ling ML Luo Yang-Hui YH Mao Shu-Lin SL

Acta crystallographica. Section E, Structure reports online 20110817 Pt 9

All non-H atoms of the title compound, C(7)H(7)NO(2), are nearly coplaner, the r.m.s. deviation being 0.0087 Å. In the crystal, the partially overlapped arrangement and the face-to-face distance of 3.466 (17) Å between parallel pyridine rings of neighboring mol-ecules indicates the existence of π-π stacking. Inter-molecular O-H⋯N hydrogen bonding and weak C-H⋯O hydrogen bonding are present in the crystal structure. ...[more]

PMID: 22065729

Similar Datasets

2-(4-Isopropyl-4-methyl-5-oxo-4,5-dihydro-1H-imidazol-2-yl)-5-methyl-nicotinic acid.

Project description:In the title herbicideh/phytocide, known as imaza-pic, C(14)H(17)N(3)O(3), the pyridine and imidazole rings are almost coplanar [dihedral angle = 3.08?(5)°]. An intra-molecular O-H?N hydrogen bond occurs. In the crystal, an N-H?O hydrogen bond links mol-ecules into a chain parallel to [010].

| S-EPMC3379288 | biostudies-literature

(±)-5-Ethyl-2-(4-isopropyl-4-methyl-5-oxo-4,5-dihydro-1H-imidazol-2-yl)nicotinic acid.

Project description:In the title compound, C(15)H(19)N(3)O(3), owing to an intra-molecular O-H?N hydrogen bond, the pyridine and imidazole rings are nearly coplanar and are twisted from each other by a dihedral angle of only 0.92?(9)°. The mol-ecules are linked through inter-molecular N-H?O hydrogen bonding, forming an infinite chain parallel to the b axis.

| S-EPMC2961475 | biostudies-literature

Nicotinic acid adenine dinucleotide phosphate analogues containing substituted nicotinic acid: effect of modification on Ca(2+) release.

Project description:Analogues of nicotinic acid adenine dinucleotide phosphate (NAADP) with substitution at either the 4- or the 5-position position of the nicotinic acid moiety have been synthesized from NADP enzymatically using Aplysia californica ADP-ribosyl cyclase or mammalian NAD glycohydrolase. Substitution at the 4-position of the nicotinic acid resulted in the loss of agonist potency for release of Ca(2+)-ions from sea urchin egg homogenates and in potency for competition ligand binding assays using [(32)P]NAADP. In contrast, several 5-substituted NAADP derivatives showed high potency for binding and full agonist activity for Ca(2+) release. 5-Azido-NAADP was shown to release calcium from sea urchin egg homogenates at low concentration and to compete with [(32)P]NAADP in a competition ligand binding assay with an IC(50) of 18 nM, indicating that this compound might be a potential photoprobe useful for specific labeling and identification of the NAADP receptor.

| S-EPMC3060082 | biostudies-literature

2-(Benzyl-carbamo-yl)nicotinic acid.

Project description:In the title compound, C14H12N2O3, the pyridine ring is twisted with respect to the phenyl ring and the carb-oxy-lic acid group at angles of 37.1?(5) and 8.1?(3)°, respectively; the phenyl ring forms a dihedral angle of 41.4?(1)° with the mean plane of the C-NH-C=O fragment. An intra-molecular O-H?O hydrogen bond occurs between the carb-oxy-lic acid and carbonyl groups. In the crystal, N-H?O hydrogen bonds link mol-ecules into a supra-molecular chain running along the a-axis direction.

| S-EPMC3790388 | biostudies-literature

Transcription profiling of Bordetella bronchiseptica RB50 nicotinic acid dose curve

Project description:B. bronchiseptica RB50 and a constitutive Bvg+ phase-locked mutant were grown at 37 degrees C in media containing a range of nicotinic acid concentrations.

2006-03-31 | E-TABM-28 | biostudies-arrayexpress

Crystal structure of human nicotinic acid phosphoribosyltransferase.

Project description:Nicotinic acid phosphoribosyltransferase (EC 2.4.2.11) (NaPRTase) is the rate-limiting enzyme in the three-step Preiss-Handler pathway for the biosynthesis of NAD. The enzyme catalyzes the conversion of nicotinic acid (Na) and 5-phosphoribosyl-1-pyrophosphate (PRPP) to nicotinic acid mononucleotide (NaMN) and pyrophosphate (PPi). Several studies have underlined the importance of NaPRTase for NAD homeostasis in mammals, but no crystallographic data are available for this enzyme from higher eukaryotes. Here, we report the crystal structure of human NaPRTase that was solved by molecular replacement at a resolution of 2.9 Å in its ligand-free form. Our structural data allow the assignment of human NaPRTase to the type II phosphoribosyltransferase subfamily and reveal that the enzyme consists of two domains and functions as a dimer with the active site located at the interface of the monomers. The substrate-binding mode was analyzed by molecular docking simulation and provides hints into the catalytic mechanism. Moreover, structural comparison of human NaPRTase with the other two human type II phosphoribosyltransferases involved in NAD biosynthesis, quinolinate phosphoribosyltransferase and nicotinamide phosphoribosyltransferase, reveals that while the three enzymes share a conserved overall structure, a few distinctive structural traits can be identified. In particular, we show that NaPRTase lacks a tunnel that, in nicotinamide phosphoribosiltransferase, represents the binding site of its potent and selective inhibitor FK866, currently used in clinical trials as an antitumoral agent.

| S-EPMC4442680 | biostudies-literature

Transcription profiling of Bordetella pertussis GMT-1 nicotinic acid dose curve

Project description:B. pertussis GMT-1 and a constitutive Bvg+ phase-locked mutant were grown at 37 degrees C in media containing a range of nicotinic acid concentrations

2006-03-31 | E-TABM-29 | biostudies-arrayexpress

Transcription profiling of 3 Bordetella bronchiseptica strains plus or minus nicotinic acid

Project description:Three B. bronchiseptica strains were grown at 37 degrees C in media containing or lacking nicotinic acid. Samples were harvested at mid-log phase and gene expression difference between the treated and untreated was measured for each strain.

2005-12-31 | E-TABM-27 | biostudies-arrayexpress

Structure of nicotinic acid mononucleotide adenylyltransferase from Bacillus anthracis.

Project description:Nicotinic acid mononucleotide adenylyltransferase (NaMNAT; EC 2.7.7.18) is the penultimate enzyme in the biosynthesis of NAD(+) and catalyzes the adenylation of nicotinic acid mononucleotide (NaMN) by ATP to form nicotinic acid adenine dinucleotide (NaAD). This enzyme is regarded as a suitable candidate for antibacterial drug development; as such, Bacillus anthracis NaMNAT (BA NaMNAT) was heterologously expressed in Escherichia coli for the purpose of inhibitor discovery and crystallography. The crystal structure of BA NaMNAT was determined by molecular replacement, revealing two dimers per asymmetric unit, and was refined to an R factor and R(free) of 0.228 and 0.263, respectively, at 2.3 A resolution. The structure is very similar to that of B. subtilis NaMNAT (BS NaMNAT), which is also a dimer, and another independently solved structure of BA NaMNAT recently released from the PDB along with two ligated forms. Comparison of these and other less related bacterial NaMNAT structures support the presence of considerable conformational heterogeneity and flexibility in three loops surrounding the substrate-binding area.

| S-EPMC2564882 | biostudies-literature

Nicotinic acid inhibits glioma invasion by facilitating Snail1 degradation.

Project description:Malignant glioma is a formidable disease that commonly leads to death, mainly due to the invasion of tumor cells into neighboring tissues. Therefore, inhibition of tumor cell invasion may provide an effective therapy for malignant glioma. Here we report that nicotinic acid (NA), an essential vitamin, inhibits glioma cell invasion in vitro and in vivo. Treatment of the U251 glioma cells with NA in vitro results in reduced invasion, which is accompanied by a loss of mesenchymal phenotype and an increase in cell-cell adhesion. At the molecular level, transcription of the adherens junction protein E-cadherin is upregulated, leading to accumulation of E-cadherin protein at the cell-cell boundary. This can be attributed to NA's ability to facilitate the ubiquitination and degradation of Snail1, a transcription factor that represses E-cadherin expression. Similarly, NA transiently inhibits neural crest migration in Xenopus embryos in a Snail1-dependent manner, indicating that the mechanism of action for NA in cell migration is evolutionarily conserved. We further show that NA injection blocks the infiltration of tumor cells into the adjacent brain tissues and improves animal survival in a rat model of glioma. These results suggest that NA treatment may be developed into a potential therapy for malignant glioma.

| S-EPMC5335718 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data